tradingkey.logo
tradingkey.logo
Search

Australia's Compumedics rises on US FDA nod for sleep testing device

ReutersSep 5, 2025 4:34 AM
facebooktwitterlinkedin

Compumedics CMP.AX rises as much as 6.4% to A$0.335, extends gains from Thursday

Medical device maker hit one-month high on Thursday after U.S. FDA granted authorisation to sell its sleep testing device Somfit®D in U.S.

Stock gains 16.4% so far this week; set to end four-week fall

CMP gains 20.8% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI